FDA advisers recommend authorization for Moderna’s COVID shot in kids 5 and under

An outside Food and Drug Administration (FDA) advisory panel on Wednesday unanimously recommended the agency grant emergency use authorization to Moderna’s COVID-19 vaccine for children between the ages of 6 months and 5 years.

The agency’s vaccine advisers voted 21 to 0 to recommend the agency authorize the vaccine.